HAVANA._ The director of Cuba’s Center of Molecular Immunology Agustín Lage praised the potential of the scientific exchange between Cuba and the United States, and announced that Cuban biotechnological products will soon be used on U.S. patients.

HAVANA._ The director of Cuba’s Center of Molecular Immunology Agustín Lage praised the potential of the scientific exchange between Cuba and the United States, and announced that Cuban biotechnological products will soon be used on U.S. patients.In a press conference in Havana, the scientist referred to future steps for reinforcing links within this sector, and announced that more than 30 Cuban patents have been approved by the U.S. Patent and Trademark Office.

In a meeting with the accredited press that covered President Barack Obama’s visit to Cuba, Lage explained that the approvals form part of a precommercial step, hence they are not subject to the sanctions established by the U.S. blockade against the island.

This is an exception because normally Cuba cannot export its biotechnological products to the United States and the U.S. patients cannot use them because the patent is Cuban, he highlighted.

The rapprochement between Cuba and the United States may well be of benefit to bilateral cooperation in biotechnology and the production of medicine, said the specialist. He also stressed that such joint work would benefit the people of the two countries, who have similar health issues with high incidence of diseases like cardiovascular afflictions and cancer.

The blockade maintained by Washington against Havana has so far hindered the development of cooperation but new possibilities are arising with the rapprochement between the two countries, Lage added.

The lifting of the restrictions would allow the U.S. population to have access to Cuban biotechnological products of proven efficiency, featuring a new lung cancer vaccine and Heberprot P (for treating diabetic foot ulcers).

HAVANA._ The director of Cuba’s Center of Molecular Immunology Agustín Lage praised the potential of the scientific exchange between Cuba and the United States, and announced that Cuban biotechnological products will soon be used on U.S. patients.Lage noted that the next step in the links between entities from the two countries would be the transition from academic to business cooperation, as well as the approval of clinical trials of Cuban products on U.S. patients.

In remarks to the press, Lage referred to the importance of Cuba’s biotechnological industry and added that the sector’s business organizations are becoming the motor of the Cuban economy, because the biotechnological products are one of Cuba’s leading exports.

The outstanding scientist also attended a business forum between Cuban and U.S. businessmen in Havana, where he said that the economy of the 21st century will be based on science.

Lage told the participants that even though he recognizes the importance of Cuba-U.S. exchanges in sectors like gastronomy, agriculture and tourism, “both countries should make the leap to high value added products.”

To reach this goal, he noted, it is necessary to attain cooperation in the public sector, as is the case in any country of the world. In most countries, the State controls high technology.

“Ignoring this would mean losing out on a great opportunity,” Lage sustained.

Share on FB Share on TT